시장보고서
상품코드
1432639

세계의 뉴트리지노믹스 시장 규모, 점유율 및 동향 분석 보고서 제품별, 최종 사용자별, 용도별, 지역별 전망 및 예측(2023-2030년)

Global Nutrigenomics Market Size, Share & Trends Analysis Report By Product (Reagents & Kits, and Services), By End User (Hospitals & Clinics, Online Platforms, and Others), By Application, By Regional Outlook and Forecast, 2023 - 2030

발행일: | 리서치사: KBV Research | 페이지 정보: 영문 208 Pages | 배송안내 : 즉시배송

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

뉴트리지노믹스 시장 규모는 2030년까지 14억 5,000만 달러에 달하고, 예측 기간 동안 16.6%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.

그러나 유전자 검사를 통해 개인별 영양에 대한 통찰력을 얻고자 하는 개인 소비자에게는 경제적인 부담이 큰 문제입니다. 이러한 검사에는 고도의 기술과 전문 지식이 필요한 경우가 많기 때문에 샘플 수집, 실험실 처리 및 데이터 분석과 관련된 비용이 전체 비용을 높이는 요인으로 작용합니다. 이러한 경제적 장벽으로 인해 많은 잠재적 사용자들이 영양유전체학의 이점을 탐색하는 것을 망설일 수 있습니다. 영양유전체 검사에 대한 보험 적용이 광범위하게 이루어지지 않는 것은 비용 문제를 더욱 악화시키고 있습니다. 제한된 상환 옵션으로 인해 소비자는 종종 이러한 검사 비용을 전액 자비로 부담하는 경우가 많습니다. 개인의 경제적 부담을 줄이기 위해서는 의료 보험사 및 의료 서비스 제공업체와의 협의를 통해 뉴트리지노믹스를 보상 계획에 포함시키는 것이 필수적입니다. 따라서 이러한 측면은 시장 수요 감소로 이어질 수 있습니다.

목차

제1장 시장 범위와 조사 방법

  • 시장의 정의
  • 목적
  • 시장 범위
  • 세분화
  • 조사 방법

제2장 시장 요람

  • 주요 하이라이트

제3장 시장 개요

  • 서론
    • 개요
      • 시장 구성과 시나리오
  • 시장에 영향을 미치는 주요 요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
    • 시장 기회
    • 시장이 해결해야 할 과제
  • Porter의 Five Forces 분석

제4장 세계 시장 : 제품별

  • 세계의 시약 및 키트 시장 : 지역별
  • 세계 서비스 시장 : 지역별

제5장 세계 시장 : 최종사용자별

  • 세계의 병원 및 클리닉 시장 : 지역별
  • 세계의 온라인 플랫폼 시장 : 지역별
  • 세계의 기타 시장 : 지역별

제6장 세계 시장 : 용도별

  • 세계의 비만 시장 : 지역별
  • 세계의 당뇨병 시장 : 지역별
  • 세계의 심혈관질환 시장 : 지역별
  • 세계의 암 연구 시장 : 지역별

제7장 세계 시장 : 지역별

  • 북미
    • 북미 시장 : 국가별
      • 미국
      • 캐나다
      • 멕시코
      • 기타 북미
  • 유럽
    • 유럽 시장 : 국가별
      • 독일
      • 영국
      • 프랑스
      • 러시아
      • 스페인
      • 이탈리아
      • 기타 유럽
  • 아시아태평양
    • 아시아태평양 시장 : 국가별
      • 중국
      • 일본
      • 인도
      • 한국
      • 싱가포르
      • 말레이시아
      • 기타 아시아태평양
  • 라틴아메리카/중동 및 아프리카
    • 라틴아메리카/중동 및 아프리카 시장 : 국가별
      • 브라질
      • 아르헨티나
      • 아랍에미리트(UAE)
      • 사우디아라비아
      • 남아프리카공화국
      • 나이지리아
      • 기타 라틴아메리카/중동 및 아프리카

제8장 기업 개요

  • Genova Diagnostics
  • Metagenics, Inc
  • Nutrigenomix Inc
  • Unilever PLC
  • The Gene Box
  • Cura Integrative Medicine
  • Fagron Genomics SL.U.(GX Sciences Inc.)
  • Xcode Life Sciences Private Limited
  • DNA Life
  • BASF SE

제9장 뉴트리지노믹스 시장을 위한 성공 필수 조건

LSH 24.03.11

The Global Nutrigenomics Market size is expected to reach $1.45 billion by 2030, rising at a market growth of 16.6% CAGR during the forecast period.

Europe, being a region with advanced healthcare infrastructure, has access to state-of-the-art technologies. Consequently, the Europe region captured $137.39 million revenue in the market in 2022. This facilitates the integration of nutrigenomics into mainstream healthcare practices, making personalized nutrition solutions more accessible to the population. Therefore, owing to these factors, the segment will witness increased growth in the upcoming years.

It explores the interaction between an individual's genetic makeup and response to specific nutrients. By understanding genetic variations, healthcare professionals can tailor dietary recommendations to meet the unique nutritional needs of each person. This approach goes beyond a one-size-fits-all model, recognizing the diversity in how people metabolize and utilize nutrients. Additionally, by analyzing an individual's genetic makeup, nutrigenomics can provide personalized risk assessments for specific lifestyle-related diseases. This information helps healthcare professionals tailor preventive strategies and dietary interventions to address each person's unique genetic vulnerabilities. Genetic factors, including lipid metabolism, blood pressure regulation, and inflammation, affect cardiovascular health. Nutrigenomics allows for personalized dietary plans that address specific genetic risk factors, contributing to the prevention of cardiovascular disorders. These aspects will drive the expansion of the market.

However, the financial burden on individual consumers seeking personalized nutrition insights through genetic testing is a major concern. As these tests often involve sophisticated technologies and specialized expertise, the expenses associated with sample collection, laboratory processing, and data interpretation contribute to the overall high cost. This financial hurdle can dissuade many potential users from exploring the benefits of nutrigenomics. The lack of widespread insurance coverage for nutrigenomic testing exacerbates the cost issue. Limited reimbursement options mean consumers often bear the full expense of these tests out of pocket. Encouraging discussions with healthcare insurers and providers to incorporate nutrigenomics into coverage plans is essential for mitigating the financial burden on individuals. Thus, these aspects can lead to decreased demand in the market.

By Product Analysis

Based on product, the market is segmented into reagents & kits and services. The reagents and kits segment held the largest revenue share in the market in 2022. The rising interest in personalized nutrition and understanding how genetics influence dietary responses have driven the demand for nutrigenomic testing. Reagents and kits play a pivotal role in facilitating the collection and analysis of genetic samples, allowing individuals to gain personalized insights into their nutritional needs. Hence, these aspects will boost the demand in the segment.

By End User Analysis.

Based on end user, the market is divided into online platforms, hospitals & clinics, and others. In 2022, the online platforms segment witnessed a substantial revenue share in the market. Online platforms are crucial in digital marketing and education within the nutrigenomics market. Companies leverage websites, social media, and online campaigns to raise awareness, educate consumers about the benefits of nutrigenomics, and promote their services. The digital space allows for targeted marketing and efficient communication with the target audience. Thus, the segment will grow rapidly in the upcoming years.

By Application Analysis

On the basis of application, the market is divided into diabetes, cardiovascular diseases, cancer research, and obesity. The obesity segment recorded the maximum revenue share in the market in 2022. The global prevalence of obesity has been on the rise, contributing to increased interest in personalized approaches to weight management. Nutrigenomics offers a tailored strategy by considering an individual's genetic makeup to provide personalized dietary recommendations for weight control. Thus, these aspects will lead to increased demand in the segment.

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. The rising awareness of the importance of personalized health and wellness has fueled interest in nutrigenomics. Consumers in North America are becoming more conscious of the impact of their genetic makeup on nutritional needs, leading to a growing demand for personalized nutrition solutions. Thus, these aspects will pose lucrative growth prospects for the segment.

List of Key Companies Profiled

  • Genova Diagnostics
  • Metagenics, Inc.
  • Nutrigenomix Inc.
  • Unilever PLC
  • The Gene Box
  • Cura Integrative Medicine
  • Fagron Genomics S.L.U. (GX Sciences Inc.)
  • Xcode Life Sciences Private Limited
  • DNA Life
  • BASF SE

Global Nutrigenomics Market Report Segmentation

By Product

  • Reagents & Kits
  • Services

By End User

  • Hospitals & Clinics
  • Online Platforms
  • Others

By Application

  • Obesity
  • Diabetes
  • Cardiovascular Diseases
  • Cancer Research

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Nutrigenomics Market, by Product
    • 1.4.2 Global Nutrigenomics Market, by End User
    • 1.4.3 Global Nutrigenomics Market, by Application
    • 1.4.4 Global Nutrigenomics Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter's Five Forces Analysis

Chapter 4. Global Nutrigenomics Market by Product

  • 4.1 Global Reagents & Kits Market by Region
  • 4.2 Global Services Market by Region

Chapter 5. Global Nutrigenomics Market by End User

  • 5.1 Global Hospitals & Clinics Market by Region
  • 5.2 Global Online Platforms Market by Region
  • 5.3 Global Others Market by Region

Chapter 6. Global Nutrigenomics Market by Application

  • 6.1 Global Obesity Market by Region
  • 6.2 Global Diabetes Market by Region
  • 6.3 Global Cardiovascular Diseases Market by Region
  • 6.4 Global Cancer Research Market by Region

Chapter 7. Global Nutrigenomics Market by Region

  • 7.1 North America Nutrigenomics Market
    • 7.1.1 North America Nutrigenomics Market by Product
      • 7.1.1.1 North America Reagents & Kits Market by Country
      • 7.1.1.2 North America Services Market by Country
    • 7.1.2 North America Nutrigenomics Market by End User
      • 7.1.2.1 North America Hospitals & Clinics Market by Country
      • 7.1.2.2 North America Online Platforms Market by Country
      • 7.1.2.3 North America Others Market by Country
    • 7.1.3 North America Nutrigenomics Market by Application
      • 7.1.3.1 North America Obesity Market by Country
      • 7.1.3.2 North America Diabetes Market by Country
      • 7.1.3.3 North America Cardiovascular Diseases Market by Country
      • 7.1.3.4 North America Cancer Research Market by Country
    • 7.1.4 North America Nutrigenomics Market by Country
      • 7.1.4.1 US Nutrigenomics Market
        • 7.1.4.1.1 US Nutrigenomics Market by Product
        • 7.1.4.1.2 US Nutrigenomics Market by End User
        • 7.1.4.1.3 US Nutrigenomics Market by Application
      • 7.1.4.2 Canada Nutrigenomics Market
        • 7.1.4.2.1 Canada Nutrigenomics Market by Product
        • 7.1.4.2.2 Canada Nutrigenomics Market by End User
        • 7.1.4.2.3 Canada Nutrigenomics Market by Application
      • 7.1.4.3 Mexico Nutrigenomics Market
        • 7.1.4.3.1 Mexico Nutrigenomics Market by Product
        • 7.1.4.3.2 Mexico Nutrigenomics Market by End User
        • 7.1.4.3.3 Mexico Nutrigenomics Market by Application
      • 7.1.4.4 Rest of North America Nutrigenomics Market
        • 7.1.4.4.1 Rest of North America Nutrigenomics Market by Product
        • 7.1.4.4.2 Rest of North America Nutrigenomics Market by End User
        • 7.1.4.4.3 Rest of North America Nutrigenomics Market by Application
  • 7.2 Europe Nutrigenomics Market
    • 7.2.1 Europe Nutrigenomics Market by Product
      • 7.2.1.1 Europe Reagents & Kits Market by Country
      • 7.2.1.2 Europe Services Market by Country
    • 7.2.2 Europe Nutrigenomics Market by End User
      • 7.2.2.1 Europe Hospitals & Clinics Market by Country
      • 7.2.2.2 Europe Online Platforms Market by Country
      • 7.2.2.3 Europe Others Market by Country
    • 7.2.3 Europe Nutrigenomics Market by Application
      • 7.2.3.1 Europe Obesity Market by Country
      • 7.2.3.2 Europe Diabetes Market by Country
      • 7.2.3.3 Europe Cardiovascular Diseases Market by Country
      • 7.2.3.4 Europe Cancer Research Market by Country
    • 7.2.4 Europe Nutrigenomics Market by Country
      • 7.2.4.1 Germany Nutrigenomics Market
        • 7.2.4.1.1 Germany Nutrigenomics Market by Product
        • 7.2.4.1.2 Germany Nutrigenomics Market by End User
        • 7.2.4.1.3 Germany Nutrigenomics Market by Application
      • 7.2.4.2 UK Nutrigenomics Market
        • 7.2.4.2.1 UK Nutrigenomics Market by Product
        • 7.2.4.2.2 UK Nutrigenomics Market by End User
        • 7.2.4.2.3 UK Nutrigenomics Market by Application
      • 7.2.4.3 France Nutrigenomics Market
        • 7.2.4.3.1 France Nutrigenomics Market by Product
        • 7.2.4.3.2 France Nutrigenomics Market by End User
        • 7.2.4.3.3 France Nutrigenomics Market by Application
      • 7.2.4.4 Russia Nutrigenomics Market
        • 7.2.4.4.1 Russia Nutrigenomics Market by Product
        • 7.2.4.4.2 Russia Nutrigenomics Market by End User
        • 7.2.4.4.3 Russia Nutrigenomics Market by Application
      • 7.2.4.5 Spain Nutrigenomics Market
        • 7.2.4.5.1 Spain Nutrigenomics Market by Product
        • 7.2.4.5.2 Spain Nutrigenomics Market by End User
        • 7.2.4.5.3 Spain Nutrigenomics Market by Application
      • 7.2.4.6 Italy Nutrigenomics Market
        • 7.2.4.6.1 Italy Nutrigenomics Market by Product
        • 7.2.4.6.2 Italy Nutrigenomics Market by End User
        • 7.2.4.6.3 Italy Nutrigenomics Market by Application
      • 7.2.4.7 Rest of Europe Nutrigenomics Market
        • 7.2.4.7.1 Rest of Europe Nutrigenomics Market by Product
        • 7.2.4.7.2 Rest of Europe Nutrigenomics Market by End User
        • 7.2.4.7.3 Rest of Europe Nutrigenomics Market by Application
  • 7.3 Asia Pacific Nutrigenomics Market
    • 7.3.1 Asia Pacific Nutrigenomics Market by Product
      • 7.3.1.1 Asia Pacific Reagents & Kits Market by Country
      • 7.3.1.2 Asia Pacific Services Market by Country
    • 7.3.2 Asia Pacific Nutrigenomics Market by End User
      • 7.3.2.1 Asia Pacific Hospitals & Clinics Market by Country
      • 7.3.2.2 Asia Pacific Online Platforms Market by Country
      • 7.3.2.3 Asia Pacific Others Market by Country
    • 7.3.3 Asia Pacific Nutrigenomics Market by Application
      • 7.3.3.1 Asia Pacific Obesity Market by Country
      • 7.3.3.2 Asia Pacific Diabetes Market by Country
      • 7.3.3.3 Asia Pacific Cardiovascular Diseases Market by Country
      • 7.3.3.4 Asia Pacific Cancer Research Market by Country
    • 7.3.4 Asia Pacific Nutrigenomics Market by Country
      • 7.3.4.1 China Nutrigenomics Market
        • 7.3.4.1.1 China Nutrigenomics Market by Product
        • 7.3.4.1.2 China Nutrigenomics Market by End User
        • 7.3.4.1.3 China Nutrigenomics Market by Application
      • 7.3.4.2 Japan Nutrigenomics Market
        • 7.3.4.2.1 Japan Nutrigenomics Market by Product
        • 7.3.4.2.2 Japan Nutrigenomics Market by End User
        • 7.3.4.2.3 Japan Nutrigenomics Market by Application
      • 7.3.4.3 India Nutrigenomics Market
        • 7.3.4.3.1 India Nutrigenomics Market by Product
        • 7.3.4.3.2 India Nutrigenomics Market by End User
        • 7.3.4.3.3 India Nutrigenomics Market by Application
      • 7.3.4.4 South Korea Nutrigenomics Market
        • 7.3.4.4.1 South Korea Nutrigenomics Market by Product
        • 7.3.4.4.2 South Korea Nutrigenomics Market by End User
        • 7.3.4.4.3 South Korea Nutrigenomics Market by Application
      • 7.3.4.5 Singapore Nutrigenomics Market
        • 7.3.4.5.1 Singapore Nutrigenomics Market by Product
        • 7.3.4.5.2 Singapore Nutrigenomics Market by End User
        • 7.3.4.5.3 Singapore Nutrigenomics Market by Application
      • 7.3.4.6 Malaysia Nutrigenomics Market
        • 7.3.4.6.1 Malaysia Nutrigenomics Market by Product
        • 7.3.4.6.2 Malaysia Nutrigenomics Market by End User
        • 7.3.4.6.3 Malaysia Nutrigenomics Market by Application
      • 7.3.4.7 Rest of Asia Pacific Nutrigenomics Market
        • 7.3.4.7.1 Rest of Asia Pacific Nutrigenomics Market by Product
        • 7.3.4.7.2 Rest of Asia Pacific Nutrigenomics Market by End User
        • 7.3.4.7.3 Rest of Asia Pacific Nutrigenomics Market by Application
  • 7.4 LAMEA Nutrigenomics Market
    • 7.4.1 LAMEA Nutrigenomics Market by Product
      • 7.4.1.1 LAMEA Reagents & Kits Market by Country
      • 7.4.1.2 LAMEA Services Market by Country
    • 7.4.2 LAMEA Nutrigenomics Market by End User
      • 7.4.2.1 LAMEA Hospitals & Clinics Market by Country
      • 7.4.2.2 LAMEA Online Platforms Market by Country
      • 7.4.2.3 LAMEA Others Market by Country
    • 7.4.3 LAMEA Nutrigenomics Market by Application
      • 7.4.3.1 LAMEA Obesity Market by Country
      • 7.4.3.2 LAMEA Diabetes Market by Country
      • 7.4.3.3 LAMEA Cardiovascular Diseases Market by Country
      • 7.4.3.4 LAMEA Cancer Research Market by Country
    • 7.4.4 LAMEA Nutrigenomics Market by Country
      • 7.4.4.1 Brazil Nutrigenomics Market
        • 7.4.4.1.1 Brazil Nutrigenomics Market by Product
        • 7.4.4.1.2 Brazil Nutrigenomics Market by End User
        • 7.4.4.1.3 Brazil Nutrigenomics Market by Application
      • 7.4.4.2 Argentina Nutrigenomics Market
        • 7.4.4.2.1 Argentina Nutrigenomics Market by Product
        • 7.4.4.2.2 Argentina Nutrigenomics Market by End User
        • 7.4.4.2.3 Argentina Nutrigenomics Market by Application
      • 7.4.4.3 UAE Nutrigenomics Market
        • 7.4.4.3.1 UAE Nutrigenomics Market by Product
        • 7.4.4.3.2 UAE Nutrigenomics Market by End User
        • 7.4.4.3.3 UAE Nutrigenomics Market by Application
      • 7.4.4.4 Saudi Arabia Nutrigenomics Market
        • 7.4.4.4.1 Saudi Arabia Nutrigenomics Market by Product
        • 7.4.4.4.2 Saudi Arabia Nutrigenomics Market by End User
        • 7.4.4.4.3 Saudi Arabia Nutrigenomics Market by Application
      • 7.4.4.5 South Africa Nutrigenomics Market
        • 7.4.4.5.1 South Africa Nutrigenomics Market by Product
        • 7.4.4.5.2 South Africa Nutrigenomics Market by End User
        • 7.4.4.5.3 South Africa Nutrigenomics Market by Application
      • 7.4.4.6 Nigeria Nutrigenomics Market
        • 7.4.4.6.1 Nigeria Nutrigenomics Market by Product
        • 7.4.4.6.2 Nigeria Nutrigenomics Market by End User
        • 7.4.4.6.3 Nigeria Nutrigenomics Market by Application
      • 7.4.4.7 Rest of LAMEA Nutrigenomics Market
        • 7.4.4.7.1 Rest of LAMEA Nutrigenomics Market by Product
        • 7.4.4.7.2 Rest of LAMEA Nutrigenomics Market by End User
        • 7.4.4.7.3 Rest of LAMEA Nutrigenomics Market by Application

Chapter 8. Company Profiles

  • 8.1 Genova Diagnostics
    • 8.1.1 Company Overview
    • 8.1.2 SWOT Analysis
  • 8.2 Metagenics, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Recent strategies and developments:
      • 8.2.2.1 Acquisition and Mergers:
    • 8.2.3 SWOT Analysis
  • 8.3 Nutrigenomix Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Recent strategies and developments:
      • 8.3.2.1 Partnerships, Collaborations, and Agreements:
      • 8.3.2.2 Product Launches and Product Expansions:
    • 8.3.3 SWOT Analysis
  • 8.4 Unilever PLC
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 SWOT Analysis
  • 8.5 The Gene Box
    • 8.5.1 Company Overview
    • 8.5.2 SWOT Analysis
  • 8.6 Cura Integrative Medicine
    • 8.6.1 Company Overview
    • 8.6.2 SWOT Analysis
  • 8.7 Fagron Genomics S.L.U. (GX Sciences Inc.)
    • 8.7.1 Company Overview
    • 8.7.2 SWOT Analysis
  • 8.8 Xcode Life Sciences Private Limited
    • 8.8.1 Company Overview
    • 8.8.2 Recent strategies and developments:
      • 8.8.2.1 Product Launches and Product Expansions:
    • 8.8.3 SWOT Analysis
  • 8.9 DNA Life
    • 8.9.1 Company Overview
    • 8.9.2 SWOT Analysis
  • 8.10. BASF SE
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 SWOT Analysis

Chapter 9. Winning Imperatives of Nutrigenomics Market

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제